Market Place
Sourcing Support
UK Cost Watchdog Clears Novo`s Wegovy For Cardio Risk Reduction
01 Apr 2026 //
FIERCE PHARMA
In Deal Fraud Dispute With Novo, KBP Looks To Revive Heart Drug
01 Apr 2026 //
FIERCE BIOTECH
Novo Nordisk Slashes Ozempic, Wegovy Prices by Up to 48% in India
31 Mar 2026 //
ECONOMICTIMES
Novo Nordisk Cuts 400 Roles At Troubled Bloomington Site
31 Mar 2026 //
FIERCE PHARMA
Weight Watchers Introduces Competitive Self-Pay Wegovy Pricing
31 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk Plans To Cut Price Of Ozempic As Generics Hit Market
31 Mar 2026 //
ECONOMICTIMES
Novo Nordisk A/S: Share Repurchase Programme
30 Mar 2026 //
GLOBENEWSWIRE
Novo`s long-acting insulin Awiqli wins FDA nod
28 Mar 2026 //
PR NEWSWIRE
Articles of Association for Novo Nordisk 2026
27 Mar 2026 //
GLOBENEWSWIRE
Resolutions from the Annual General Meeting of Novo Nordisk A/S
26 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk Triple Agonist UBT251 Cuts HbA1c by 2.16% in Phase 2
25 Mar 2026 //
GLOBENEWSWIRE
Novo Faces Access Challenges Despite Strong Wegovy Launch
25 Mar 2026 //
BIOSPACE
Government Enhances Oversight On Unauthorized GLP-1 Sales
24 Mar 2026 //
BUSINESS STD
Weight Loss Drug Market Sees Surge From Pharma Companies
24 Mar 2026 //
ECONOMICTIMES
Lexicon, Novo Launch Oral LX9851 Phase 1 Obesity Trial
23 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S: Share Repurchase Programme
23 Mar 2026 //
GLOBENEWSWIRE
Novo To Track Generic Surge As Semaglutide Goes Off Patent
21 Mar 2026 //
ECONOMICTIMES
Novo To Track Generic Surge As Semaglutide Goes Off Patent
20 Mar 2026 //
ECONOMICTIMES
Natco Launches Rs 1,290 Semaglutide Following Novo Nordisk
20 Mar 2026 //
ECONOMICTIMES
Roche Halts SMA Drug, Boosting Rivals` Prospects
20 Mar 2026 //
BIOSPACE
FDA Approves Wegovy HD to Maximize Weight Loss
20 Mar 2026 //
PR NEWSWIRE
Novo Nordisk A/S Launches Share Buyback Program
16 Mar 2026 //
GLOBENEWSWIRE
Patent Expirations Push Biopharma Industry Toward A Tougher 2026
13 Mar 2026 //
FIERCE PHARMA
Novo’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
13 Mar 2026 //
BIOSPACE
Novo Holdings Announces 2025 Annual Results
12 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk receives FDA warning linked to US inspection in 2025
11 Mar 2026 //
REUTERS
FDA Issues Form 483 to Novo Nordisk
10 Mar 2026 //
FDA
Novo Nordisk’s Receives FDA Warning Letter
10 Mar 2026 //
FDA
Novo Nordisk Boosts Semaglutide Over Eli Lilly In Market Share
09 Mar 2026 //
ECONOMICTIMES
Hims & Hers Announces Strategic Shift For US Weight Loss Business
09 Mar 2026 //
BUSSINESSWIRE
Novo Nordisk Ends GLP-1 Dispute With Hims & Hers
09 Mar 2026 //
BIOSPACE
Incyte Lung Cancer Expansion Hit by Issues at Novo Catalent Site
09 Mar 2026 //
BIOSPACE
Novo Nordisk Launches Share Repurchase Program
09 Mar 2026 //
GLOBENEWSWIRE
FDA Cites Novo Nordisk Again For Misleading GLP-1 AD
05 Mar 2026 //
RAPS
Novo Earns FDA Untitled Letter For Apple-Inspired Ozempic Ad
04 Mar 2026 //
FIERCE PHARMA
Keytruda Hangs On To Best Seller Crown As Glp-1s Gain Ground
04 Mar 2026 //
BIOSPACE
North Carolina Attracts Amgen, Roche For Next-Gen Obesity Drug
03 Mar 2026 //
BIOSPACE
Novo Charts $500M Ireland Upgrade To Produce Wegovy Pill
03 Mar 2026 //
FIERCE PHARMA
Novo Allocates $506M To Convert Irish Plant For Oral Wegovy
02 Mar 2026 //
BIOSPACE
Novo Nordisk Expands Athlone, Ireland Facility By Over 400M Euros
02 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S: Share Repurchase Programme
02 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk Elects Employee Representatives To Board
02 Mar 2026 //
GLOBENEWSWIRE
Abbott Signs Pact With Novo Nordisk To Offer Semaglutide
28 Feb 2026 //
ECONOMICTIMES
FDA approves Novo`s Sogroya as the first and only FDA Approval
28 Feb 2026 //
PR NEWSWIRE
Novo, Vivtex in up to US$2.1 bn Obesity Deal
27 Feb 2026 //
GLOBENEWSWIRE
Lilly Tops Novo In Weight Loss Again, This Time On The Oral Front
26 Feb 2026 //
BIOSPACE
Novo`s UBT251 Hits 19.7% Weight Loss in China Phase 2 Trial
25 Feb 2026 //
GLOBENEWSWIRE
Novo Plans List Price Reduction For Semaglutide Drugs In `27
24 Feb 2026 //
FIERCE PHARMA
Novo`s CagriSema Trial Deals Blow in Obesity drug Battle Lilly
24 Feb 2026 //
REUTERS
Novo Nordisk A/S: Share Repurchase Programme
23 Feb 2026 //
GLOBENEWSWIRE
Madrigal Embraces Novo Competition As MASH Drug Gains Steam
19 Feb 2026 //
FIERCE PHARMA
Madrigal embraces Novo Competition as MASH Drug Gains Steam
18 Feb 2026 //
FIERCE PHARMA
Dr Reddy`s Readies Day-1 Launch Of Semaglutide Generic
18 Feb 2026 //
ECONOMICTIMES
EU Approves Enhanced Wegovy for Obesity in Adults
17 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S - Share Repurchase Programme
16 Feb 2026 //
GLOBENEWSWIRE
Oral Wegovy Brings In Thousands Of New GLP-1 Patients
12 Feb 2026 //
BIOSPACE
Novo Nordisk Board Members And Executives Trade Company Shares
11 Feb 2026 //
GLOBENEWSWIRE
Novo, Lilly Earnings Ignite Weight Loss Drama, Gene Therapy Buzz
11 Feb 2026 //
BIOSPACE
Novo Nordisk Board Members And Executives Trade Company Shares
10 Feb 2026 //
GLOBENEWSWIRE
FDA Cites Novo Nordisk For Airing Misleading Wegovy Ad
10 Feb 2026 //
RAPS
